Fischer Medical Ventures Limited has made a regulatory disclosure pursuant to Regulation 24(1) read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding a board appointment at its subsidiary.
Director Details
Name: Mr. Chan Sing En
DIN: 11300541
Appointment Date: October 27, 2026
Term: As per the resolution passed in accordance with the laws of Singapore
Professional Profile
Mr. Chan Sing En is an investment professional with over three decades of experience spanning Southeast Asia and Australia. He has built a distinguished career in private equity, corporate finance, and operational turnarounds. Currently, he serves as Principal and Director of SovCapital Pte Ltd, Singapore, where he leads strategic investment and restructuring initiatives for both private and public companies. He specializes in reverse takeovers, capital raising, and pre-IPO consultancy.
Additionally, Mr. Chan serves on the advisory board of FTAG Investment Bank in Malaysia, contributing to high-profile corporate finance transactions and cross-border deals, including the NASDAQ listing of a global supercar brand. He is a graduate of Pepperdine University, USA, with a degree in Business Administration.
Subsidiary Information
FMV Global Innovations Pte. Ltd., Singapore is characterized as an "unlisted material wholly owned subsidiary" of Fischer Medical Ventures Limited.